September 13, 2017 — The NHS Business Services Authority has approved the listing of the FreeStyle Libre® flash glucose monitoring system in the Drug Tariff (under section 9A: Detection Sensor, interstitial fluid for glucose). This means, subject to local health economy approval, it will be available for reimbursement via the NHS across England and Wales, NHS Scotland and Health and Social Care in Northern Ireland from 1st November 2017.
This announcement follows the NICE MIB110 (www.nice.org.uk/advice/mib110), published on 1st July, and more recently the Diabetes UK Consensus Statement endorsed by ABCD
We would encourage members to engage with the purchasers of health services in their localities to agree clinically sensible access policies. The consensus statement might be a good starting point.
